U.S. News & World Report · 15h
Ozempic Shows Some Promise for Alcohol Use Disorder
The results suggest the potential of semaglutide – the main ingredient in Ozempic and Novo’s higher-dose weight-loss drug Wegovy – and similar drugs “to fill an unmet need for the treatment of alcohol use disorder,” study leader Klara Klein of the University of North Carolina School of Medicine said in a statement.
Firstpost · 3h
Can weight-loss drug Ozempic help reduce alcohol consumption?
A new study published in the JAMA Psychiatry gives the strongest evidence that semaglutide — the active ingredient in Ozempic and the weight-loss drug Wegovy — could genuinely help individuals struggling with alcohol addiction drink less and crave alcohol less frequently.
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results